The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 22, 2023
Filed:
Aug. 29, 2018
Applicants:
Musc Foundation for Research Development, Charleston, SC (US);
Leukogene Therapeutics Incorporated, Mt. Pleasant, SC (US);
Inventors:
Nathan G. Dolloff, Mt. Pleasant, SC (US);
Reeder M. Robinson, Charleston, SC (US);
Allen B. Reitz, Lansdale, PA (US);
Haiyan Bian, Princeton, NJ (US);
Assignees:
MUSC Foundation for Research Development, Charleston, SC (US);
Lukogene Therapeutics Incorporated, Mt. Pleasant, SC (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07C 39/38 (2006.01); C07C 43/225 (2006.01); C07C 61/29 (2006.01); C07C 69/708 (2006.01); C07C 233/02 (2006.01); C07C 233/58 (2006.01); C07D 317/70 (2006.01); C07D 317/52 (2006.01); C07D 319/14 (2006.01); C07D 263/52 (2006.01); C07C 69/712 (2006.01); A61P 35/00 (2006.01); C07C 62/32 (2006.01); C07C 69/757 (2006.01); C07C 235/40 (2006.01); C07C 235/34 (2006.01); C07C 49/255 (2006.01); C07C 59/72 (2006.01); C07C 65/11 (2006.01);
U.S. Cl.
CPC ...
C07D 317/70 (2013.01); A61P 35/00 (2018.01); C07C 39/38 (2013.01); C07C 43/225 (2013.01); C07C 49/255 (2013.01); C07C 59/72 (2013.01); C07C 61/29 (2013.01); C07C 62/32 (2013.01); C07C 65/11 (2013.01); C07C 69/708 (2013.01); C07C 69/712 (2013.01); C07C 69/757 (2013.01); C07C 233/02 (2013.01); C07C 233/58 (2013.01); C07C 235/34 (2013.01); C07C 235/40 (2013.01); C07D 263/52 (2013.01); C07D 317/52 (2013.01); C07D 319/14 (2013.01); C07C 2601/14 (2017.05); C07C 2602/08 (2017.05);
Abstract
The present invention relates to compounds of formula (I): including any stereochemically isomeric form thereof, or pharmaceutically acceptable salts thereof, for the treatment of, for example, cancer.